Latest It Compliance News

EQ Resources has opened FY2027 with record revenue, EBITDA, profit and operating cashflow as tungsten production climbed 81% quarter-on-quarter. The company has also set its first full-year production, cost and capital expenditure targets, while expansion work and a Spanish regulatory issue remain key execution tests.

Aurora Labs has secured $6 million to expand production of its additively manufactured turbojet systems, with Walkinshaw Group joining the placement as a strategic investor. The raise will fund equipment, production infrastructure and the company’s push from early deliveries towards scaled commercial manufacturing.

Vault Minerals delivered record FY2026 earnings, generated A$887.9 million in operating cash flow and ended the year debt-free before agreeing to combine with Genesis Minerals. The company now enters FY2027 fully exposed to spot gold prices, with its Leonora expansion and merger vote setting the next major tests.

Norfolk Metals ended FY2026 with a sharply higher loss, just A$807,974 in cash and a material uncertainty over its ability to continue as a going concern. Its proposed Chilean copper expansion now depends on a minimum A$75 million capital raising, ASX re-compliance and completion of the Ciclón and Condor transactions.

MCS Services reported a $467,000 net cash outflow for the September quarter, leaving $1.305 million in cash and no operating business after its Traffic Business sale. Its securities remain suspended while the company explores a potential acquisition and ASX recompliance transaction with no agreement yet signed.

ASF Group finished FY2026 with A$5.19 million in cash, no outstanding borrowings and a materially stronger net asset position after selling several investments. But the A$4.09 million profit was still largely disposal-led, while operating cash flow remained negative and recurring revenue declined.

Immutep’s pivotal TACTI-004 lung cancer trial dominates a difficult FY26, with the failure widening the loss to A$79.3 million and triggering an impairment, cost cuts and a root cause review. The biotech retains A$68.9 million in cash, cash equivalents and term deposits, while its remaining investment case rests on IMP761 and selected efti studies.

The Star Entertainment returned to positive quarterly EBITDA in Q1 FY27, with Sydney and Gold Coast revenue recording year-on-year growth for the first time since quarterly reporting began. The improvement comes alongside negative reported operating cash flow, continuing casino licence restrictions and unresolved going-concern uncertainties.

Eve Health Group (ASX:EVE) says it knows of no undisclosed information that would explain a sharp fall and surge in trading volume. The company suggested selling by a formerly associated shareholder may have contributed, without identifying the seller or quantifying the disposal.

Bougainville Copper has asked the ASX to reinstate quotation trading after lodging its delayed half-year report, but the exchange has not yet approved a resumption. The company has acknowledged repeated reporting failures and introduced tighter internal controls.

Elementos has secured approval for the 8.1km access corridor at its Oropesa tin project in Spain and made its Robledollano smelter option unconditional. The company ended September with A$38.6 million in cash, but still needs primary permits, financing and offtake agreements before a final investment decision.

Sarytogan Graphite has completed a 50,000-tonne-a-year upstream graphite DFS and extended copper porphyry exploration in Kazakhstan, but held only A$1.015 million in cash at quarter end. The company estimates that balance represents 0.88 quarters of funding at its recent spending rate, leaving project financing and potential capital raising firmly in focus.